Dr. Uttam Yashwant Patil's appointment as CEO of ABVC BioPharma is expected to have a positive impact on the company's stock price in the short term. His extensive experience in the pharmaceutical industry will likely bring valuable insights and leadership to the company, potentially leading to improved performance and growth.